Abstract #577: Dulaglutide improves kidney fibrosis biomarker levels in patients with type 2 diabetes and moderate-to-severe chronic kidney disease

Authors

Katherine Tuttle, Providence St. Joseph HealthFollow
Jonathan Wilson
Kevin Duffin
Fady Botros
Kathleen Kelly-Boruff
Federica Genovese
Morten Karsdal
Yanzhu Lin
Hui-Rong Qian

Document Type

Presentation

Publication Date

9-23-2020

Publication Title

European Association for the Study of Diabetes

Clinical Institute

Kidney & Diabetes

Department

Endocrinology

Comments

Virtual Meeting

Recommended Citation

Tuttle, Katherine; Wilson, Jonathan; Duffin, Kevin; Botros, Fady; Kelly-Boruff, Kathleen; Genovese, Federica; Karsdal, Morten; Lin, Yanzhu; and Qian, Hui-Rong, "Abstract #577: Dulaglutide improves kidney fibrosis biomarker levels in patients with type 2 diabetes and moderate-to-severe chronic kidney disease" (2020). Articles, Abstracts, and Reports. 3759.
https://digitalcommons.providence.org/publications/3759